Frontotemporal dementia caused by CHMP2B mutations

Current Alzheimer Research

Volumn 8, Issue 3, 2011, Pages 246-251

  Isaacs, A M ^a   Johannsen, P ^b   Holm, I ^d,e   Nielsen, J E ^b,c   Fisher, Elizabeth ^f   Rossor, Martin ^f   Gade, Anders ^f   Thusgaard, Tove ^f   Gydesen, Susanne ^f   Englund, Elisabet ^g   Brown, Jerry ^h   Collinge, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d RANDERS REGIONAL HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f Mental Health Services CPH   (Denmark)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Autophagy; Brain imaging; CHMP2B; Endosome; Frontotemporal dementia; Lysosome; Neuropathology

Indexed keywords

CHMP2B PROTEIN; CHROMOSOME PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 3; COMPUTER ASSISTED TOMOGRAPHY; ENDOSOME; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INDEL MUTATION; INTRACELLULAR SIGNALING; LYSOSOME; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FRONTOTEMPORAL DEMENTIA; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 79956277415     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511795563764     Document Type: Article

References (64)

1. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554 (1998).
2. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58: 1803-1809 (2001).
3. Lillo P, Hodges JR. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci 16: 1131-1135 (2009).
4. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl) 114: 5-22 (2007).
5. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66: 41-48 (2006).
6. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54 Suppl 5: S15-S19 (2003).
7. Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord 17: 282-286 (2004).
8. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117: 15-18 (2009).
9. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132: 2922-2931 (2009).
10. Seelaar H, Klijnsma KY, de K, I, van der LA, Chiu WZ, Azmani A, et al. Frequency of ubiquitin and FUS-positive, TDP-43- negative frontotemporal lobar degeneration. J Neurol 25(5): 747-53 (2010).
11. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119: 1-4 (2010).
12. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause taunegative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919 (2006).
13. Cruts M, Gijselinck I, van der ZJ, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920-924 (2006).
14. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705 (1998).
15. Benajiba L, Le B, I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65: 470-473 (2009).
16. Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 30: E974-E983 (2009).
17. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosincontaining protein. Nat Genet 36: 377-381 (2004).
18. Van Langenhove T, van der ZJ, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74: 366-371 (2010).
19. van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 17: 313-322 (2008).
20. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, et al. Mutations in the endosomal ESCRTIIIcomplex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806-808 (2005).
21. Lindquist SG, Braedgaard H, Svenstrup K, Isaacs AM, Nielsen JE. Frontotemporal dementia linked to chromosome 3 (FTD-3)- current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Eur J Neurol 15: 667-670 (2008).
22. Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, Froud K, et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet 19: 2228-38 (2010).
23. Urwin H, Ghazi-Noori S, Collinge J, Isaacs A. The role of CHMP2B in frontotemporal dementia. Biochem Soc Trans 37: 208-212 (2009).
24. Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59: 1585-1594 (2002).
25. Rohrer JD, Ahsan RL, Isaacs AM, Nielsen JE, Ostergaard L, Scahill R, et al. Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation. Dement Geriatr Cogn Disord 27: 182-186 (2009).
26. Eskildsen SF, Ostergaard LR, Rodell AB, Ostergaard L, Nielsen JE, Isaacs AM, et al. Cortical volumes and atrophy rates in FTD-3CHMP2B mutation car riers and related non-arriers. Neuroimage 45: 713-721 (2009).
27. Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM. A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3. J Neuropathol Exp Neurol 66: 884-891 (2007).
28. Holm IE, Isaacs AM, Mackenzie IR. Absence of FUSimmunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 118: 719-720 (2009).
29. Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, et al. FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration. Acta Neurophathol 120: 33-41 (2010).
30. Cataldo AM, Mathews PM, Boiteau AB, Hassinger LC, Peterhoff CM, Jiang Y, et al. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. Am J Pathol 173: 370-384 (2008).
31. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157: 277-286 (2000).
32. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 17: 6142-6151 (1997).
33. Yancopoulou D, Crowther RA, Chakrabarti L, Gydesen S, Brown JM, Spillantini MG. Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3). J Neuropathol Exp Neurol 62: 878-882 (2003).
34. Jellinger KA, Bancher C. Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 8: 367-376 (1998).
35. Yamada M. Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 23: 311-317 (2003).
36. Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis. Mol Biol Cell 11: 467-480 (2000).
37. Houlden H, King RH, Muddle JR, Warner TT, Reilly MM, Orrell RW, et al. A novel RAB7 mutation associated with ulceromutilating neuropathy. Ann Neurol 56: 586-590 (2004).
38. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer- Grumbach M, Kwon JM, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 72: 722-727 (2003).
39. Katzmann DJ, Odorizzi G, Emr SD. Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3: 893-905 (2002).
40. Kantamneni S, Holman D, Wilkinson KA, Nishimune A, Henley JM. GISP increases neurotransmitter receptor stability by downregulating ESCRT-mediated lysosomal degradation. Neurosci Lett 452: 106-110 (2009).
41. Kantamneni S, Holman D, Wilkinson KA, Correa SA, Feligioni M, Ogden S, et al. GISP binding to TSG101 increases GABA receptor stability by down-regulating ESCRT-mediated lysosomal degradation. J Neurochem 107: 86-95 (2008).
42. Ahmad ST, Sweeney ST, Lee JA, Sweeney NT, Gao FB. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia. Proc Natl Acad Sci USA 106: 12168-12173 (2009).
43. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV. Toll-like receptors in neurodegeneration. Brain Res Rev 59: 278-292 (2009).
44. Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 335: 1-32 (2009).
45. Gordon PB, Seglen PO. Prelysosomal convergence of autophagic and endocytic pathways. Biochem Biophys Res Commun 151: 40-47 (1988).
46. Tooze J, Hollinshead M, Ludwig T, Howell K, Hoflack B, Kern H. In exocrine pancreas, the basolateral endocytic pathway converges with the autophagic pathway immediately after the early endosome. J Cell Biol 111: 329-345 (1990).
47. Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 179: 485-500 (2007).
48. Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol 17: 1561-1567 (2007).
49. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, et al. Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117: 4837-4848 (2004).
50. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64: 113-122 (2005).
51. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, et al. Macroautophagy--a novel Beta-amyloid peptidegenerating pathway activated in Alzheimer's disease. J Cell Biol 171: 87-98 (2005).
52. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12: 25-31 (1997).
53. Boellaard JW, Schlote W, Tateishi J. Neuronal autophagy in experimental Creutzfeldt-Jakob's disease. Acta Neuropathol (Berl) 78: 410-418 (1989).
54. Boellaard JW, Kao M, Schlote W, Diringer H. Neuronal autophagy in experimental scrapie. Acta Neuropathol (Berl) 82: 225-228 (1991).
55. Sikorska B, Liberski PP, Giraud P, Kopp N, Brown P. Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study. Int J Biochem Cell Biol 36: 2563-2573 (2004).
56. Sikorska B, Liberski PP, Brown P. Neuronal autophagy and aggresomes constitute a consistent part of neurodegeneration in experimental scrapie. Folia Neuropathol 45: 170-178 (2007).
57. Liberski PP, Yanagihara R, Wells GA, Gibbs CJ, Jr., Gajdusek DC. Comparative ultrastructural neuropathology of naturally occurring bovine spongiform encephalopathy and experimentally induced scrapie and Creutzfeldt-Jakob disease. J Comp Pathol 106: 361-381 (1992).
58. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889 (2006).
59. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884 (2006).
60. Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 5: e9872 (2010).
61. Blair IP, Vance C, Durnall JC, Williams KL, Thoeng A, Shaw CE, et al. CHMP2B mutations are not a common cause of familial or sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 79: 849-850 (2008).
62. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67: 1074-1077 (2006).
63. Rizzu P, van Mil SE, Anar B, Rosso SM, Kaat LD, Heutink P, et al. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Am J Med Genet B Neuropsychiatr Genet 141B: 944-946 (2006).
64. Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, et al. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett 398: 83-84 (2006).